Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model
- PMID: 23828905
- DOI: 10.1093/carcin/bgt243
Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model
Abstract
Honokiol is known to suppress the growth of cancer cells; however, to date, its antiperitoneal dissemination effects have not been studied in an orthotopic mouse model. In the present study, we evaluated the antiperitoneal dissemination potential of Honokiol in an orthotopic mouse model and assessed associations with tumor growth factor-β1 (TGFβ1) and cells stimulated by a carcinogen, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Our results demonstrate that tumor growth, peritoneal dissemination and peritoneum or organ metastasis of orthotopically implanted MKN45 cells were significantly decreased in Honokiol-treated mice and that endoplasmic reticulum (ER) stress was induced. Honokiol-treated tumors showed increased epithelial signatures such as E-cadherin, cytokeratin-18 and ER stress marker. In contrast, decreased expression of vimentin, Snail and tumor progression locus 2 (Tpl2) was also noted. TGFβ1 and MNNG-induced downregulation of E-cadherin and upregulation of Tpl2 were abrogated by Honokiol treatment. The effect of Tpl2 inhibition in cancer cells or endothelial cells was associated with inactivation of CCAAT/enhancer binding protein B, nuclear factor kappa-light-chain-enhancer of activated B cell and activator protein-1 and suppression of vascular endothelial growth factor. Inhibition of Tpl2 in gastric cancer cells by small interfering RNA or pharmacological inhibitor was found to effectively reduce growth ability and vessel density in vivo. Honokiol-induced reversal of epithelial-to-mesenchymal transition (EMT) and ER stress-induced apoptosis via Tp12 may involve the paralleling processes. Taken together, our results suggest that the therapeutic inhibition of Tpl2 by Honokiol thwarts both gastric tumor growth and peritoneal dissemination by inducing ER stress and inhibiting EMT.
Similar articles
-
Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.Mol Oncol. 2015 Apr;9(4):834-49. doi: 10.1016/j.molonc.2014.12.009. Epub 2015 Jan 6. Mol Oncol. 2015. PMID: 25619450 Free PMC article.
-
Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.Cancer Lett. 2019 Feb 1;442:113-125. doi: 10.1016/j.canlet.2018.10.026. Epub 2018 Nov 1. Cancer Lett. 2019. PMID: 30391358
-
The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination.Oncotarget. 2014 Sep 15;5(17):7788-804. doi: 10.18632/oncotarget.2307. Oncotarget. 2014. PMID: 25226618 Free PMC article.
-
Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs.Adv Exp Med Biol. 2016;928:245-265. doi: 10.1007/978-3-319-41334-1_11. Adv Exp Med Biol. 2016. PMID: 27671820 Review.
-
Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.Theranostics. 2020 Jul 9;10(18):8343-8364. doi: 10.7150/thno.45848. eCollection 2020. Theranostics. 2020. PMID: 32724474 Free PMC article. Review.
Cited by
-
Honokiol as a Radiosensitizing Agent for Colorectal cancers.Curr Colorectal Cancer Rep. 2013 Dec;9(4):10.1007/s11888-013-0191-4. doi: 10.1007/s11888-013-0191-4. Curr Colorectal Cancer Rep. 2013. PMID: 24307888 Free PMC article.
-
Honokiol suppresses metastasis of renal cell carcinoma by targeting KISS1/KISS1R signaling.Int J Oncol. 2015;46(6):2293-8. doi: 10.3892/ijo.2015.2950. Epub 2015 Apr 2. Int J Oncol. 2015. PMID: 25846316 Free PMC article.
-
Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation.Acta Pharmacol Sin. 2019 Sep;40(9):1219-1227. doi: 10.1038/s41401-019-0240-x. Epub 2019 Jun 24. Acta Pharmacol Sin. 2019. PMID: 31235819 Free PMC article.
-
c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells.Cell Cycle. 2016 Sep;15(17):2309-20. doi: 10.1080/15384101.2016.1201253. Epub 2016 Jun 24. Cell Cycle. 2016. PMID: 27341160 Free PMC article.
-
Targeting E-cadherin expression with small molecules for digestive cancer treatment.Am J Transl Res. 2019 Jul 15;11(7):3932-3944. eCollection 2019. Am J Transl Res. 2019. PMID: 31396310 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous